carmustine has been researched along with Flushing in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Flushing: A transient reddening of the face that may be due to fever, certain drugs, exertion, or stress.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe seven patients who developed symptoms including severe headache, circumoral paresthesia, and facial flushing during high-dose carmustine (BCNU) infusion as part of the preparative regimen for autologous peripheral blood stem cell (PBSC) transplantation for metastatic breast cancer." | 7.69 | Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion. ( Bruton, J; Champlin, R; Ippoliti, C; Mehra, R; Przepiorka, D; Woo, MH, 1997) |
| "We describe seven patients who developed symptoms including severe headache, circumoral paresthesia, and facial flushing during high-dose carmustine (BCNU) infusion as part of the preparative regimen for autologous peripheral blood stem cell (PBSC) transplantation for metastatic breast cancer." | 3.69 | Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion. ( Bruton, J; Champlin, R; Ippoliti, C; Mehra, R; Przepiorka, D; Woo, MH, 1997) |
| " Average pharmacokinetic parameters for bioavailable plasma BCNU, calculated on the basis of a one-compartment model, include an elimination constant of 0." | 1.27 | Pharmacokinetics and immediate effects of high-dose carmustine in man. ( Antman, K; Eder, JP; Frei, E; Henner, WD; Peters, WP; Schnipper, L, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woo, MH | 1 |
| Ippoliti, C | 1 |
| Bruton, J | 1 |
| Mehra, R | 1 |
| Champlin, R | 1 |
| Przepiorka, D | 1 |
| Henner, WD | 1 |
| Peters, WP | 1 |
| Eder, JP | 1 |
| Antman, K | 1 |
| Schnipper, L | 1 |
| Frei, E | 1 |
2 other studies available for carmustine and Flushing
| Article | Year |
|---|---|
Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion.
Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Ductal, Breast; Carmustine; Cytokine | 1997 |
Pharmacokinetics and immediate effects of high-dose carmustine in man.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Carmustine; Chromatography, High Pre | 1986 |